Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Neoadjuvant therapy for breast cancer: updates and proceedings from the Seventh Annual Meeting of the Canadian Consortium for Locally Advanced Breast Cancer.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Affiliation:
      Department of Surgery, The Ottawa Hospital Cancer Centre, Ottawa, ON
      Department of Oncology, Juravinski Cancer Centre, Hamilton, ON
      Department of Oncology, BC Cancer, Vancouver, BC
      Department of Surgery, Centre des maladies du sein, chu de Québec, Quebec City, QC
      Department of Pathology, Sunnybrook Health Sciences Centre, Toronto, ON
      Department of Oncology, CancerCare Manitoba, Winnipeg, MB
      Department of Surgery, Sir Mortimer B. Davis Jewish General Hospital, Montreal, QC
      Department Oncology, Cross Cancer Institute, Edmonton, AB
    • Abstract:
      Therapy for breast cancer involves a complex interplay of three main treatment modalities: surgery, systemic therapy, and radiation therapy. The Canadian Consortium for Locally Advanced Breast Cancer (LABC) was established with the goal to convene a strong multidisciplinary team of breast oncology clinicians and scientists who are dedicated to the advancement of LABC research and treatment, with a vision to drive progress through increased collaboration across disciplines and throughout Canada. The most recent meeting in May 2017 highlighted the latest evidence and literature about the optimal use of neoadjuvant systemic therapy in breast cancer. There is a need for increased clinical and scientific collaboration and the development of guidelines for the use of emerging treatment strategies. The interactive meeting sessions fostered unique opportunities for academic debate and nurtured collaboration between the attendees.
    • Journal Subset:
      Biomedical; Canada; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed
    • ISSN:
      1198-0052
    • MEDLINE Info:
      NLM UID: 9502503
    • Publication Date:
      In Process
    • Publication Date:
      20181113
    • Accession Number:
      http://dx.doi.org/10.3747/co.25.4153
    • Accession Number:
      132888528
  • Citations
    • ABNT:
      ARNAOUT, A. et al. Neoadjuvant therapy for breast cancer: updates and proceedings from the Seventh Annual Meeting of the Canadian Consortium for Locally Advanced Breast Cancer. Current Oncology, [s. l.], v. 25, n. 5, p. e490–e498, 2018. DOI 10.3747/co.25.4153. Disponível em: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=ccm&AN=132888528. Acesso em: 14 ago. 2020.
    • AMA:
      Arnaout A, Lee J, Gelmon K, et al. Neoadjuvant therapy for breast cancer: updates and proceedings from the Seventh Annual Meeting of the Canadian Consortium for Locally Advanced Breast Cancer. Current Oncology. 2018;25(5):e490-e498. doi:10.3747/co.25.4153
    • APA:
      Arnaout, A., Lee, J., Gelmon, K., Poirier, B., Lu, F. I., Akra, M., Boileau, J. F., Tonkin, K., Li, H., Illman, C., Simmons, C., & Grenier, D. (2018). Neoadjuvant therapy for breast cancer: updates and proceedings from the Seventh Annual Meeting of the Canadian Consortium for Locally Advanced Breast Cancer. Current Oncology, 25(5), e490–e498. https://doi.org/10.3747/co.25.4153
    • Chicago/Turabian: Author-Date:
      Arnaout, A., J. Lee, K. Gelmon, B. Poirier, F. I. Lu, M. Akra, J. F. Boileau, et al. 2018. “Neoadjuvant Therapy for Breast Cancer: Updates and Proceedings from the Seventh Annual Meeting of the Canadian Consortium for Locally Advanced Breast Cancer.” Current Oncology 25 (5): e490–98. doi:10.3747/co.25.4153.
    • Harvard:
      Arnaout, A. et al. (2018) ‘Neoadjuvant therapy for breast cancer: updates and proceedings from the Seventh Annual Meeting of the Canadian Consortium for Locally Advanced Breast Cancer’, Current Oncology, 25(5), pp. e490–e498. doi: 10.3747/co.25.4153.
    • Harvard: Australian:
      Arnaout, A, Lee, J, Gelmon, K, Poirier, B, Lu, FI, Akra, M, Boileau, JF, Tonkin, K, Li, H, Illman, C, Simmons, C & Grenier, D 2018, ‘Neoadjuvant therapy for breast cancer: updates and proceedings from the Seventh Annual Meeting of the Canadian Consortium for Locally Advanced Breast Cancer’, Current Oncology, vol. 25, no. 5, pp. e490–e498, viewed 14 August 2020, .
    • MLA:
      Arnaout, A., et al. “Neoadjuvant Therapy for Breast Cancer: Updates and Proceedings from the Seventh Annual Meeting of the Canadian Consortium for Locally Advanced Breast Cancer.” Current Oncology, vol. 25, no. 5, Oct. 2018, pp. e490–e498. EBSCOhost, doi:10.3747/co.25.4153.
    • Chicago/Turabian: Humanities:
      Arnaout, A., J. Lee, K. Gelmon, B. Poirier, F. I. Lu, M. Akra, J. F. Boileau, et al. “Neoadjuvant Therapy for Breast Cancer: Updates and Proceedings from the Seventh Annual Meeting of the Canadian Consortium for Locally Advanced Breast Cancer.” Current Oncology 25, no. 5 (October 2018): e490–98. doi:10.3747/co.25.4153.
    • Vancouver/ICMJE:
      Arnaout A, Lee J, Gelmon K, Poirier B, Lu FI, Akra M, et al. Neoadjuvant therapy for breast cancer: updates and proceedings from the Seventh Annual Meeting of the Canadian Consortium for Locally Advanced Breast Cancer. Current Oncology [Internet]. 2018 Oct [cited 2020 Aug 14];25(5):e490–8. Available from: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=ccm&AN=132888528